» Articles » PMID: 27777789

FoxO1 Interacts with Transcription Factor EB and Differentially Regulates Mitochondrial Uncoupling Proteins Via Autophagy in Adipocytes

Overview
Date 2016 Oct 26
PMID 27777789
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondrial uncoupling proteins (UCPs) are inducible and play an important role in metabolic and redox homeostasis. Recent studies have suggested that FoxO1 controls mitochondrial biogenesis and morphology, but it remains largely unknown how FoxO1 may regulate mitochondrial UCPs. Here we show that FoxO1 interacted with transcription factor EB (Tfeb), a key regulator of autophagosome and lysosome, and mediated the expression of UCP1, UCP2 and UCP3 differentially via autophagy in adipocytes. UCP1 was down-regulated but UCP2 and UCP3 were upregulated during adipocyte differentiation, which was associated with increased Tfeb and autophagy activity. However, inhibition of FoxO1 suppressed Tfeb and autophagy, attenuating UCP2 and UCP3 but increasing UCP1 expression. Pharmacological blockade of autophagy recapitulated the effects of FoxO1 inhibition on UCPs. Chromatin immunoprecipitation assay demonstrated that FoxO1 interacted with Tfeb by directly binding to its promoter, and silencing FoxO1 led to drastic decrease in Tfeb transcript and protein levels. These data provide the first line of evidence that FoxO1 interacts with Tfeb to regulate autophagy and UCP expression in adipocytes. Dysregulation of FoxO1→autophagy→UCP pathway may account for metabolic changes in obesity.

Citing Articles

Metabolic Signaling as a Driver of T Cell Aging.

Choi M, Choi S, Cho M, Kim C Immune Netw. 2025; 25(1):e14.

PMID: 40078788 PMC: 11896665. DOI: 10.4110/in.2025.25.e14.


Autophagy in Muscle Regeneration: Mechanisms, Targets, and Therapeutic Perspective.

Chu Y, Yuan X, Tao Y, Yang B, Luo J Int J Mol Sci. 2024; 25(22).

PMID: 39595972 PMC: 11593790. DOI: 10.3390/ijms252211901.


White-to-Beige and Back: Adipocyte Conversion and Transcriptional Reprogramming.

Boychenko S, Egorova V, Brovin A, Egorov A Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931457 PMC: 11206576. DOI: 10.3390/ph17060790.


FoxO1 as a tissue-specific therapeutic target for type 2 diabetes.

Teaney N, Cyr N Front Endocrinol (Lausanne). 2023; 14:1286838.

PMID: 37941908 PMC: 10629996. DOI: 10.3389/fendo.2023.1286838.


Fibroblast growth factor 21 (FGF21) attenuates tacrolimus-induced hepatic lipid accumulation through transcription factor EB (TFEB)-regulated lipophagy.

Zhang Z, Xu L, Qiu X, Yang X, Lian Z, Wei X J Zhejiang Univ Sci B. 2023; 24(6):485-495.

PMID: 37309040 PMC: 10264170. DOI: 10.1631/jzus.B2200562.


References
1.
Yamada E, Singh R . Mapping autophagy on to your metabolic radar. Diabetes. 2012; 61(2):272-80. PMC: 3266408. DOI: 10.2337/db11-1199. View

2.
Cheng Z, Schmelz E, Liu D, Hulver M . Targeting mitochondrial alterations to prevent type 2 diabetes--evidence from studies of dietary redox-active compounds. Mol Nutr Food Res. 2014; 58(8):1739-49. DOI: 10.1002/mnfr.201300747. View

3.
Rousset S, Alves-Guerra M, Mozo J, Miroux B, Cassard-Doulcier A, Bouillaud F . The biology of mitochondrial uncoupling proteins. Diabetes. 2004; 53 Suppl 1:S130-5. DOI: 10.2337/diabetes.53.2007.s130. View

4.
Ramirez-Zacarias J, Castro-Munozledo F . Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry. 1992; 97(6):493-7. DOI: 10.1007/BF00316069. View

5.
Liu L, Zheng L, Zou P, Brooke J, Smith C, Long Y . FoxO1 antagonist suppresses autophagy and lipid droplet growth in adipocytes. Cell Cycle. 2016; 15(15):2033-41. PMC: 4968963. DOI: 10.1080/15384101.2016.1192732. View